{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-048347","form_type":"8-K","ticker":"CBIO","cik":"0001253689","company_name":"CRESCENT BIOPHARMA, INC.","filed_at":"2026-07-15T20:58:01+00:00","discovered_at":"2026-07-15T20:59:07.388078+00:00","generated_at":"2026-07-15T20:59:10.720299+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Crescent Biopharma prices $125M public offering of shares and pre-funded warrants","bullets":["Priced 8,094,793 ordinary shares at $14.50/share and 525,897 pre-funded warrants at $14.499 each.","Gross proceeds ~$125M; net proceeds ~$115.9M (~$133.5M if underwriters' option exercised in full).","Underwriters granted 30-day option to purchase up to 1,293,103 additional ordinary shares.","Net proceeds expected to fund operations into second half of 2028; closing expected July 16, 2026.","Jefferies, TD Cowen, Guggenheim Securities, Cantor act as joint book-running managers."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-048347","json":"https://secwatch.observer/filing/0001628280-26-048347.json","markdown":"https://secwatch.observer/filing/0001628280-26-048347.md","text":"https://secwatch.observer/filing/0001628280-26-048347.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1253689/000162828026048347/0001628280-26-048347-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1253689/000162828026048347/cbio-20260714.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-15T20:59:10.720299+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}